ClinicalTrials.Veeva

Menu

Role of Concentration of Biomarkers S100B and NSE in Serum in Mild and Moderate Head Trauma

U

University Clinical Centre of Kosova

Status

Unknown

Conditions

Biomarkers

Treatments

Other: Following S100B and NSE in head trauma

Study type

Observational

Funder types

Other

Identifiers

NCT02988102
FKelmendi

Details and patient eligibility

About

In pediatric age groups communication difficulties very sometimes may present further obstacles in obtaining a detailed injury history and early identification of TBI symptoms.

Most emergency management protocols are focused exclusively on the identification of the relatively small number of patients who may require operative intervention, as early surgery is believed to improve outcome.

Full description

However early rehabilitation can also be effective for the much larger number of patients who do not require surgery[1] In addition, Hall and others recently reported that low doses of ionizing radiation to the brain in infancy may influence cognitive abilities in adulthood. [2] Accordingly, increased serum concentrations of, for example S100B ( a calcium-binding protein present in high concentrations in glial cells) and neurone-specific enolase ( NSE: a cytoplasmatic enzyme occuring predominantly in neurones ) have been demonstrated to reflect the presence and severity of brain tissue damage in acute head injuries. [3] In both pediatric age and adults.

Enrollment

70 estimated patients

Sex

All

Ages

1 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Only head trauma without any other body injury

Exclusion criteria

  • Blood thinner, hydrocephalus , previous brain infarcts, encephalopathy, birth trauma.

Trial contacts and locations

1

Loading...

Central trial contact

Fatos Kelmendi; Agon Mekaj, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems